The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
First results of a phase II trial to assess the efficacy of efavirenz in patients with metastatic androgen-independent prostate cancer.
Nadine Houede
No relevant relationships to disclose
Marina Pulido
No relevant relationships to disclose
Loic Mourey
No relevant relationships to disclose
Florence Joly
No relevant relationships to disclose
Jean Marc Ferrero
No relevant relationships to disclose
Carine Bellera
No relevant relationships to disclose
Franck Priou
No relevant relationships to disclose
Caroline Lalet
No relevant relationships to disclose
Audrey Laroche
Employment or Leadership Position - Alienor Farma
Mireille Canal-Raffin
No relevant relationships to disclose
Pier Vi Piazza
Employment or Leadership Position - Alienor Farma